63 related articles for article (PubMed ID: 369687)
1. Phase II study of high-dose methotrexate in patients with advanced malignant melanoma.
Fisher RI; Chabner BA; Myers CE
Cancer Treat Rep; 1979 Jan; 63(1):147-8. PubMed ID: 369687
[No Abstract] [Full Text] [Related]
2. High-dose methotrexate in malignant melanoma.
Karakousis CP; Carlson M
Cancer Treat Rep; 1979 Aug; 63(8):1405-7. PubMed ID: 314335
[TBL] [Abstract][Full Text] [Related]
3. Phase II study of the combination of carmustine and 6-thioguanine in advanced malignant melanoma.
Morton RF; Creagan ET; Veeder MH; Elson DL; Laurie JA; Nelimark RA; Chang MN
Cancer Treat Rep; 1987 Apr; 71(4):429-30. PubMed ID: 3548962
[No Abstract] [Full Text] [Related]
4. Phase II trial of VM-26 in patients with metastatic malignant melanoma.
Bellet RE; Catalno RB; Mastrangelo MJ; Berd D; Koons LS
Cancer Treat Rep; 1978 Mar; 62(3):445-7. PubMed ID: 348313
[No Abstract] [Full Text] [Related]
5. Phase II study with sequential L-asparaginase and methotrexate in advanced refractory breast cancer.
Yap HY; Benjamin RS; Blumenschein GR; Hortobagyi GN; Tashima CK; Buzdar AU; Bodey GP
Cancer Treat Rep; 1979 Jan; 63(1):77-83. PubMed ID: 369695
[TBL] [Abstract][Full Text] [Related]
6. Phase II study of i.v. menogaril in patients with malignant melanoma: a National Cancer Institute of Canada Clinical Trials Group Study.
McCulloch PB; Eisenhauer EA; Shibata HR; Young VP
Cancer Treat Rep; 1987; 71(7-8):771-2. PubMed ID: 2955887
[No Abstract] [Full Text] [Related]
7. Phase II study of high-dose megestrol acetate in patients with advanced malignant melanoma.
Creagan ET; Schutt AJ; Ahmann DL; Green SJ
Cancer Treat Rep; 1982 May; 66(5):1239-40. PubMed ID: 7083227
[No Abstract] [Full Text] [Related]
8. Benefits and adverse drug experiences during long-term methotrexate treatment of 248 psoriatics.
Nyfors A
Dan Med Bull; 1978 Oct; 25(5):208-11. PubMed ID: 359259
[No Abstract] [Full Text] [Related]
9. Phase II trial of pyrazofurin in malignant melanoma.
Budman D; Currie V; Wittes R
Cancer Treat Rep; 1977 Dec; 61(9):1733-4. PubMed ID: 340040
[No Abstract] [Full Text] [Related]
10. Phase II study of low-dose methotrexate in advanced osteosarcoma followed by escalation after disease progression: a study of the Soft Tissue and Bone Sarcoma Group of the European Organization for Research on Treatment of Cancer.
Wagener DJ; van Oosterom AT; Mulder JH; Somers R; Mouridsen HT; Cortes Funes H; Thomas D; Sylvester R
Cancer Treat Rep; 1986 May; 70(5):615-8. PubMed ID: 3458532
[TBL] [Abstract][Full Text] [Related]
11. Methotrexate treatment of advanced head and neck cancers: a dose response evaluation.
Woods RL; Fox RM; Tattersall MH
Cancer Treat Rep; 1981; 65 Suppl 1():155-9. PubMed ID: 7034929
[TBL] [Abstract][Full Text] [Related]
12. Mitolactol chemotherapy for malignant melanoma: a phase II study.
Malden LT; Coates AS; Milton GW; McCarthy WH; Levi JA; Woods RL; Byrne MJ; Reynolds PM; Fox RM; Hedley DW
Cancer Treat Rep; 1984; 68(7-8):1045-6. PubMed ID: 6744338
[TBL] [Abstract][Full Text] [Related]
13. Phase II trial of carboplatin in advanced malignant melanoma.
Evans LM; Casper ES; Rosenbluth R
Cancer Treat Rep; 1987 Feb; 71(2):171-2. PubMed ID: 3542209
[TBL] [Abstract][Full Text] [Related]
14. Phase II study of mitolactol in advanced malignant melanoma.
Murray N; Silver H; Shah A; Wilson K
Cancer Treat Rep; 1985 Jun; 69(6):723-4. PubMed ID: 4016778
[No Abstract] [Full Text] [Related]
15. Evaluation of S12363, a novel vinca alkaloid drug in the treatment of advanced malignant melanoma. A phase II study.
Stanley AJ; Kaprielian R; Retsas S
Anticancer Res; 1993; 13(1):31-2. PubMed ID: 8476226
[TBL] [Abstract][Full Text] [Related]
16. Methotrexate in advanced endometrial carcinoma. A phase II trial of the Gynecologic Oncology Group.
Muss HB; Blessing JA; Hatch KD; Soper JT; Webster KD; Kemp GM
Am J Clin Oncol; 1990 Feb; 13(1):61-3. PubMed ID: 2407104
[TBL] [Abstract][Full Text] [Related]
17. Phase II study of the combination of vinblastine, bleomycin, and cisplatin in advanced malignant melanoma.
Creagan ET; Ahmann DL; Schutt AJ; Green SJ
Cancer Treat Rep; 1982 Mar; 66(3):567-9. PubMed ID: 6174231
[No Abstract] [Full Text] [Related]
18. Methotrexate with thymidine protection or rescue in advanced head and neck cancer: a phase II study.
Schornagel JH; Leyva A; Pinedo HM
Cancer Treat Rep; 1984 Mar; 68(3):543-5. PubMed ID: 6704983
[No Abstract] [Full Text] [Related]
19. Phase II trial of 4-demethoxydaunorubicin in patients with advanced malignant melanoma.
Stanton G; Casper ES; Friedman B
Cancer Treat Rep; 1985; 69(7-8):915-6. PubMed ID: 3860298
[No Abstract] [Full Text] [Related]
20. Phase II study of mitolactol in metastatic malignant melanoma.
Simmonds MA; Lipton A; Harvey HA; Ellison N; White DS
Cancer Treat Rep; 1985 Jan; 69(1):65-7. PubMed ID: 3967260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
